Rapid laboratory diagnosis of human cytomegalovirus infection using monoclonal antibody

C L Kao1, C N Lee

  • 1School of Medical Technology, National Taiwan University, Taipei, R.O.C.

Insights

A new monoclonal antibody E.13 enables rapid detection of human cytomegalovirus (HCMV) in clinical samples. This method significantly reduces diagnosis time from days to just one day, improving early detection of HCMV infections.

Area of Science:

  • Virology
  • Immunology
  • Cell Biology

Background:

  • Human cytomegalovirus (HCMV) is a significant pathogen requiring rapid diagnostic methods.
  • Current diagnostic techniques for HCMV can be time-consuming, delaying patient management.

Purpose of the Study:

  • To evaluate the efficacy of a novel monoclonal antibody (E.13) for the early detection of HCMV in cell cultures.
  • To assess the feasibility of using this method for rapid diagnosis in clinical virology laboratories.

Main Methods:

  • Indirect immunofluorescence staining (IF) using monoclonal antibody E.13 to detect HCMV early antigen in infected human embryonic lung fibroblast (HELF) cells.
  • Shell vial culture method for HCMV isolation from clinical urine specimens.
  • Comparison with the conventional tube culture method for HCMV detection.

Main Results:

  • HCMV antigen was detectable by IF as early as 6 hours post-inoculation, peaking at 14 hours and remaining stable for 72 hours.
  • The shell vial culture method with E.13 antibody provided results in 16–18 hours, compared to 10.9 days for conventional culture.
  • The sensitivity and specificity of the E.13 antibody method were 93.06% and 99.22%, respectively, against conventional methods.

Conclusions:

  • Monoclonal antibody E.13 is a sensitive and reliable tool for the rapid detection of HCMV early antigen.
  • The shell vial culture combined with E.13 antibody offers a significant advancement for rapid HCMV diagnosis in clinical settings.